tiprankstipranks
SynAct Pharma AB (SE:SYNACT)
:SYNACT
Sweden Market
SYNACT
SynAct Pharma AB
RESEARCH TOOLSreports
Want to see SE:SYNACT full AI Analyst Report?

SynAct Pharma AB (SYNACT) Financial Statements

2 Followers

SynAct Pharma AB Financial Overview

SynAct Pharma AB's market cap is currently kr936.48M. The company's EPS TTM is kr-0.43; its P/E ratio is -10.42; SynAct Pharma AB is scheduled to report earnings on February 18, 2026, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profitkr 0.00kr -617.00Kkr -778.00Kkr -1.06Mkr -88.00K
Operating Incomekr -117.15Mkr -89.98Mkr -224.50Mkr -105.70Mkr -76.70M
EBITDAkr -117.15Mkr -15.40Mkr -222.70Mkr -105.71Mkr -76.62M
Net Incomekr -110.83Mkr -82.40Mkr -215.81Mkr -99.20Mkr -69.30M
Balance Sheet
Cash & Short-Term Investmentskr 53.41Mkr 61.21Mkr 62.40Mkr 108.25Mkr 24.00M
Total Assetskr 220.52Mkr 270.52Mkr 228.02Mkr 142.60Mkr 38.37M
Total Debtkr 1.81Mkr 1.88Mkr 637.00Kkr 2.06Mkr 3.09M
Net Debtkr -51.60Mkr -59.33Mkr -61.76Mkr -106.18Mkr -20.91M
Total Liabilitieskr 50.23Mkr 56.35Mkr 51.83Mkr 16.08Mkr 17.50M
Stockholders' Equitykr 170.29Mkr 214.17Mkr 176.19Mkr 126.52Mkr 20.87M
Cash Flow
Free Cash Flowkr -97.33Mkr -89.20Mkr -100.18Mkr -117.56Mkr -65.00M
Operating Cash Flowkr -97.33Mkr -89.20Mkr -100.18Mkr -117.56Mkr -65.00M
Investing Cash Flowkr 0.00kr 0.00kr 370.00Kkr 27.00Kkr -6.00K
Financing Cash Flowkr 90.46Mkr 87.41Mkr 53.98Mkr 200.71Mkr 74.32M
Currency in SEK

SynAct Pharma AB Earnings and Revenue History

Income Statement >

SynAct Pharma AB Debt to Assets

Balance Sheet >

SynAct Pharma AB Cash Flow

Cash Flow >

SynAct Pharma AB Forecast EPS vs Actual EPS

Earnings >